Vigencell: Orphan Drug Designation for VT-EBV-N by EMA for NK/T Cell Lymphoma Treatment
2023-12-20 09:28:38 “Safety and effectiveness proven by global regulatory agencies” Entered 2023.12.20 18:28 Views 3 Entered 2023.12.20 18:28 Modified 2023.12.20 18:38 Views 3 [사진=바이젠셀]Vigencell, an immune cell therapy company, has been designated as an orphan drug by the European Medicines Agency (EMA). The drug (VT-EBV-N), which received orphan drug designation this time, is an immunotherapy … Read more